| |
| |
|
| Insider
Information: |
Biller Scott |
| Relationship: |
Chief Scientific Officer |
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
33,729 |
|
|
Indirect Shares
|
53,059 |
|
|
| Direct
Value |
$1,602,465 |
|
|
|
Indirect Value
|
$2,520,833 |
|
|
| Total
Shares |
86,788 |
|
|
| Total
Value |
$4,123,298 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Agios Pharmaceuticals Inc |
AGIO |
Chief Scientific Officer |
2019-06-11 |
33,729 |
2019-06-11 |
53,059 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
121 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 3 of 5
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| AGIO |
Agios Pharmaceuticals Inc |
Chief Scientific Officer |
• – – |
2015-12-31 |
4 |
OE |
$31.64 |
$174,020 |
D/D |
5,500 |
39,570 |
0 |
- |
|
| AGIO |
Agios Pharmaceuticals Inc |
Chief Scientific Officer |
• – – |
2015-12-31 |
4 |
AS |
$65.27 |
$358,985 |
D/D |
(5,500) |
34,070 |
0 |
- |
|
| AGIO |
Agios Pharmaceuticals Inc |
Chief Scientific Officer |
• – – |
2016-01-07 |
4 |
OE |
$0.47 |
$7,013 |
D/D |
15,000 |
49,070 |
0 |
- |
|
| AGIO |
Agios Pharmaceuticals Inc |
Chief Scientific Officer |
• – – |
2016-02-03 |
4 |
OE |
$0.47 |
$4,675 |
D/D |
10,000 |
59,070 |
0 |
- |
|
| AGIO |
Agios Pharmaceuticals Inc |
Chief Scientific Officer |
• – – |
2016-06-08 |
4 |
AS |
$65.00 |
$1,787,500 |
D/D |
(27,500) |
59,070 |
0 |
- |
|
| AGIO |
Agios Pharmaceuticals Inc |
Chief Scientific Officer |
• – – |
2016-06-08 |
4 |
OE |
$0.47 |
$174,766 |
D/D |
27,500 |
86,570 |
0 |
- |
|
| AGIO |
Agios Pharmaceuticals Inc |
Chief Scientific Officer |
• – – |
2016-06-10 |
4 |
OE |
$0.47 |
$7,106 |
D/D |
15,200 |
74,270 |
0 |
- |
|
| AGIO |
Agios Pharmaceuticals Inc |
Chief Scientific Officer |
• – – |
2016-09-20 |
4 |
AS |
$50.00 |
$250,000 |
I/I |
(5,000) |
21,000 |
0 |
- |
|
| AGIO |
Agios Pharmaceuticals Inc |
Chief Scientific Officer |
• – – |
2016-10-05 |
4 |
AS |
$55.00 |
$275,000 |
I/I |
(5,000) |
16,000 |
0 |
- |
|
| AGIO |
Agios Pharmaceuticals Inc |
Chief Scientific Officer |
• – – |
2016-11-09 |
4 |
AS |
$60.00 |
$172,320 |
I/I |
(2,872) |
13,128 |
0 |
- |
|
| AGIO |
Agios Pharmaceuticals Inc |
Chief Scientific Officer |
• – – |
2016-11-10 |
4 |
AS |
$60.00 |
$127,680 |
I/I |
(2,128) |
11,000 |
0 |
- |
|
| AGIO |
Agios Pharmaceuticals Inc |
Chief Scientific Officer |
• – – |
2016-11-14 |
4 |
AS |
$65.00 |
$1,787,500 |
D/D |
(27,500) |
48,270 |
0 |
- |
|
| AGIO |
Agios Pharmaceuticals Inc |
Chief Scientific Officer |
• – – |
2016-11-14 |
4 |
OE |
$0.47 |
$337,037 |
D/D |
27,500 |
75,770 |
0 |
- |
|
| AGIO |
Agios Pharmaceuticals Inc |
Chief Scientific Officer |
• – – |
2016-11-14 |
4 |
AS |
$65.00 |
$325,000 |
I/I |
(5,000) |
6,000 |
0 |
- |
|
| AGIO |
Agios Pharmaceuticals Inc |
Chief Scientific Officer |
• – – |
2016-12-22 |
4 |
GD |
$0.00 |
$0 |
D/D |
7,800 |
40,470 |
0 |
- |
|
| AGIO |
Agios Pharmaceuticals Inc |
Chief Scientific Officer |
• – – |
2017-03-20 |
4 |
AS |
$55.00 |
$354,090 |
D/D |
(6,438) |
15,470 |
0 |
- |
|
| AGIO |
Agios Pharmaceuticals Inc |
Chief Scientific Officer |
• – – |
2017-03-20 |
4 |
OE |
$0.47 |
$53,930 |
D/D |
6,438 |
15,975 |
0 |
- |
|
| AGIO |
Agios Pharmaceuticals Inc |
Chief Scientific Officer |
• – – |
2017-04-03 |
4 |
AS |
$58.03 |
$124,532 |
D/D |
(2,146) |
15,734 |
0 |
- |
|
| AGIO |
Agios Pharmaceuticals Inc |
Chief Scientific Officer |
• – – |
2017-04-03 |
4 |
OE |
$9.05 |
$19,421 |
D/D |
2,146 |
17,880 |
0 |
- |
|
| AGIO |
Agios Pharmaceuticals Inc |
Chief Scientific Officer |
• – – |
2017-06-21 |
4 |
OE |
$0.47 |
$40,245 |
D/D |
7,292 |
3,264 |
0 |
- |
|
| AGIO |
Agios Pharmaceuticals Inc |
Chief Scientific Officer |
• – – |
2017-06-21 |
4 |
AS |
$55.00 |
$236,060 |
D/D |
(4,292) |
264 |
0 |
- |
|
| AGIO |
Agios Pharmaceuticals Inc |
Chief Scientific Officer |
• – – |
2017-06-23 |
4 |
OE |
$0.47 |
$1,403 |
D/D |
3,000 |
6,264 |
0 |
- |
|
| AGIO |
Agios Pharmaceuticals Inc |
Chief Scientific Officer |
• – – |
2017-07-07 |
4 |
AS |
$55.00 |
$118,030 |
D/D |
(2,146) |
6,264 |
0 |
- |
|
| AGIO |
Agios Pharmaceuticals Inc |
Chief Scientific Officer |
• – – |
2017-07-07 |
4 |
OE |
$9.05 |
$19,421 |
D/D |
2,146 |
8,410 |
0 |
- |
|
| AGIO |
Agios Pharmaceuticals Inc |
Chief Scientific Officer |
• – – |
2017-08-01 |
4 |
AS |
$55.05 |
$118,137 |
D/D |
(2,146) |
6,264 |
0 |
- |
|
121 Records found
|
|
Page 3 of 5 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
